SCHEMBL13615629

SCHEMBL13615629

CC(C)C1c2ccccc2N(c2ccccc2)c2ccccc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.42
ALDH1A1 P00352 4/20 0.39
NPSR1 Q6W5P4 2/20 0.39
CES2 O00748 1/20 0.39
BCHE P06276 1/20 0.39
GAA P10253 1/20 0.39
CES1 P23141 1/20 0.39
CHRM1 P11229 1/20 0.38
KMT2A Q03164 5/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
MEN1 O00255 4/20 0.36
HTR7 P34969 3/20 0.36
HTR2B P41595 3/20 0.36
TMEM97 Q5BJF2 3/20 0.36
SIGMAR1 Q99720 3/20 0.36
HTR1A P08908 2/20 0.36
SLC6A2 P23975 2/20 0.36
ADRA2A P08913 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31657761 0.78 MAOA (0.40) MAPTALDH1A1NPSR1CES2BCHE
SCHEMBL13615627 0.78 HDAC4 (0.46) GAAKMT2AMEN1HTR2BSLC6A2
SCHEMBL16835542 0.74 GAA (0.40) ALDH1A1NPSR1CES2BCHEGAA
SCHEMBL10053598 0.73 ESR1 (0.35) MAPTKMT2AMEN1KDM4E
SCHEMBL6524996 0.72 CHEK1 (0.41) MAPTALDH1A1NPSR1CES2BCHE
SCHEMBL29886595 0.72 CHEK1 (0.41) MAPTALDH1A1NPSR1CES2BCHE
SCHEMBL30060869 0.71 ALDH1A1 (0.50) ALDH1A1NPSR1CES2BCHEGAA
SCHEMBL1573901 0.71 ALDH1A1 (0.50) ALDH1A1NPSR1CES2BCHEGAA
SCHEMBL22068219 0.71 ALDH1A1 (0.50) ALDH1A1NPSR1CES2BCHEGAA
SCHEMBL22705247 0.71 GAA (0.36) MAPTALDH1A1NPSR1CES2BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090273277-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2009-11-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090273277-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, ORMDL3, CHRM2 MAPT 3474/4885ALDH1A1 818/4885NPSR1 2689/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.